摘要 |
<p>This invention relates to a N1-(halogenocyclopropyl)-substituted pyridonecarboxylic acid derivative represented by the following formula (I): <CHEM> wherein X<1> is a halogen atom or a hydrogen atom; X<2> is a halogen atom; R<1> is a hydrogen atom, a hydroxyl group, a thiol group, a halogenomethyl group, an amino group, an alkyl group or an alkoxy group which may have a substituent group; R<2> is a group represented by the following formula (II): <CHEM> wherein R<3> and R<4> are independently a hydrogen atom or an alkyl group and n is an integer of 1 or 2; A is a nitrogen atom or a partial structure of the following formula (III): <CHEM> wherein X<3> is a hydrogen atom, a halogen atom, a cyano group, an amino group, an alkyl group, a halogenomethyl group, an alkoxyl group or a halogenomethoxyl group which may have a substituent group; and R is a hydrogen atom, a phenyl group, an acetoxymethyl group, a pivaloyloxymethyl group, an ethoxycarbonyl group, a choline group, a dimethylaminoethyl group, a 5-indanyl group, a phthalidynyl group, a 5-alkyl-2-oxo-1,3-dioxol-4-ylmethyl group, a 3-acetoxy-2-oxobutyl group, an alkyl group, an alkoxymethyl group or a phenylalkyl group, and provides a heterocyclic compound useful as antibacterial drugs.</p> |
申请人 |
DAIICHI PHARMACEUTICAL CO., LTD. |
发明人 |
TAKEMURA, MAKOTO;KIMURA, YOUICHI;KAWAKAMI, KATSUHIRO;KIMURA, KENICHI;OHKI, HITOSHI;MATSUHASHI, NORIKAZU;KAWATO, HARUKO |